Your Mounjaro price guide · October 2026
Weight Loss Injectable Medication in the UK (October 2026)
The licensed weight loss injectables in the UK are once-weekly Mounjaro (tirzepatide), once-weekly Wegovy (semaglutide) and daily liraglutide (Saxenda and similar products). All are prescription-only and are used alongside a reduced-calorie diet and more physical activity. Mounjaro is the only one that activates both GIP and GLP-1 receptors.1
One pen. Four weekly doses.
New customers£40 off your first order with code FIRST40. Standard price £169.99.

From your first consultation to ongoing care.
- GPhC-registered UK pharmacy
- Prescriber assessment
- Temperature-controlled delivery
- Advice from our pharmacy team
Compare UK Mounjaro Prices
Prices checked 10 October 2026
| Provider | 2.5mg | 5mg | 7.5mg | 10mg | 12.5mg | 15mg | Notes |
|---|---|---|---|---|---|---|---|
| £129.99First orderReorders £144.99 | £178.99First orderReorders £193.99 | £239.99First orderReorders £254.99 | £250.99First orderReorders £265.99 | £279.99First orderReorders £294.99 | £289.99First orderReorders £304.99 | Consultation and next-day tracked delivery included | |
| Boots Online Doctor | £179.00 | £199.00 | £259.00 | £299.00 | £319.00 | £339.00 | Free click & collect; cold-chain home delivery chargeable |
| Asda Online Doctor | £148.97 | £188.97 | £248.97 | £278.97 | £287.47 | £298.97 | Refrigerated delivery from £4.50; free click & collect |
| MedExpress | £179.99 | £189.99 | £249.99 | £279.99 | £299.99 | £309.99 | Delivery £2.90 to £3.95; new-customer discount at checkout |
| Simple Online Pharmacy | £169.00 | £199.99 | £259.99 | £279.99 | £299.99 | £319.99 | Delivery £4.99 per order |
| Oxford Online Pharmacy | £143.96 | £188.96 | £248.96 | £278.96 | £288.96 | £309.95 | Free consultation; cold delivery £5.49 |
| Chemist4U | £148.00 | £188.00 | £248.00 | £278.00 | £288.00 | £298.00 | Consultation included; free temperature-controlled delivery |
| Chemist Click | £163.99 | £173.99 | £232.99 | £259.99 | £279.99 | £299.49 | Cold-chain delivery charged; £20 off with code |
| Click Pharmacy | £169.99 | £189.99 | £239.99 | £269.99 | £289.99 | £299.99 | Free assessment; delivery £3.50 to £7.95 |
| Medino | £147.99 | £169.99 | £249.99 | £269.99 | £299.99 | £319.99 | Consultation and delivery included |
Prices collected weekly from each provider's published price list.
A quick overview
What to know
before you start.
-
Mounjaro and Wegovy are once-weekly injections. Liraglutide products such as Saxenda are daily injections supplied at 6mg/ml.
-
Every licensed weight loss injectable is prescription-only and needs a prescriber to judge whether it suits you.
-
Mounjaro is the only injectable here that activates both GIP and GLP-1 receptors; semaglutide acts on GLP-1 alone.
-
Weight loss on these medicines is gradual. Think in months, not days, and judge progress by the trend rather than single weigh-ins.
-
NHS access to Mounjaro is being phased in over several years, so many eligible people choose regulated private treatment.
In this guide
01 · The core answer
What counts as a weight loss injectable medication?
A weight loss injectable medication is a prescription medicine, given by injection under the skin, that is licensed to help adults manage their weight. In the UK that means three families of product: tirzepatide (Mounjaro), semaglutide (Wegovy) and liraglutide (Saxenda and products such as Erly). Mounjaro is a once-weekly prescription medicine made by Eli Lilly, licensed in the UK for weight management in adults and for type 2 diabetes.1
These medicines are not stimulants, fat burners or supplements. They work on gut-hormone signalling so that you feel fuller sooner and less hungry between meals, which makes a reduced-calorie diet easier to follow. They are tools alongside food and activity changes, not replacements for them.1
| Medicine | How often | Action | Dose ladder |
|---|---|---|---|
| Mounjaro (tirzepatide) | Once weekly | Activates GIP and GLP-1 receptors | 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, 15mg |
| Wegovy (semaglutide) | Once weekly | Single-action GLP-1 medicine | 0.25mg, 0.5mg, 1mg, 1.7mg, 2.4mg |
| Liraglutide (Saxenda, Erly) | Daily | Daily injection; prescriber advises on details | Supplied at 6mg/ml |
02 · Your decision
Is an injectable relevant to you?
An injectable is relevant if you are an adult whose weight affects your health, you have tried diet and activity changes, and you want medical support. A prescriber decides whether a product is suitable, based on your health history, current medicines and weight-related conditions. Mounjaro is supplied only after an online consultation reviewed by a GPhC-registered prescriber, and it is used alongside a reduced-calorie diet and increased physical activity. Individual results vary.
You are probably a poor fit for self-directed use if you are looking for a quick fix, if you want to take less than the prescribed dose, or if you hope to buy without any assessment. Anyone offering to supply a prescription medicine without a consultation or prescription is a warning sign. The MHRA publishes counterfeit medicine alerts and runs the Yellow Card scheme for reporting problems.7
Questions to settle before you choose: do you prefer a weekly or a daily injection; are you also managing type 2 diabetes; which other medicines do you take; and are you comfortable with a pen injection under the skin? If you are comparing routes, see how an injectable weight loss prescription works in practice.
03 · Next step
What to do next
If you want to explore Mounjaro, the next step is a free online consultation. Your first 2.5mg pen costs £129.99 with code FIRST40 (standard price £169.99); see the Mounjaro pen prices and consultation page, where all six doses are in stock. If you would rather talk through options first, our weight loss clinic page explains the support we offer, including ongoing monthly reviews with the prescribing team.
04 · How injectables work
How weight loss injections work in the body
Weight loss injections work by copying natural gut hormones that signal fullness and slow digestion. Tirzepatide, the active ingredient in Mounjaro, activates the GIP and GLP-1 receptors at once. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.1
In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet. That is the central idea: the medicine changes appetite signals, and you still do the work of eating differently and moving more. It does not burn fat directly, and it does not act as a stimulant.1
The dual action is what distinguishes Mounjaro from single-action GLP-1 medicines such as semaglutide (Wegovy and Ozempic). Wegovy is the weight management brand of semaglutide, and its licensed maintenance dose is 2.4mg once weekly.1 Liraglutide products belong to the GLP-1 family too, but they are given daily rather than weekly.
Why weekly versus daily matters
A once-weekly pen means a single injection day to remember, whereas a daily product means building the injection into every day. Some people value the simplicity of weekly dosing, particularly on busy or travelling weeks. Others prefer the rhythm of a daily routine. Neither is better in itself; it is a practical choice that you can discuss with the prescriber. Our injectable weight loss medication list sets the options out side by side.
Why there is no instant effect
These medicines do not work like a painkiller. The body adjusts to them over weeks, which is why every course begins at a low dose and builds. Tirzepatide stays in the system for a while after the final dose, taking roughly four to five weeks to clear, and there is no way to speed this up. Nothing needs doing while it clears.1
What the trials tell us, and what they do not
The SURMOUNT-1 trial measured tirzepatide results over 72 weeks, and the STEP 1 trial studied semaglutide in a similar population.2 Those were separate studies with different designs, so you should not read their headline numbers against each other as if one beat the other. Trial averages also do not predict your own result. Your response depends on dose, tolerance, diet, activity and the rest of your health picture. SURMOUNT-5 was the first large head-to-head trial of tirzepatide and semaglutide, and a prescriber is the best person to help you weigh the options in your own case.
05 · Mounjaro in detail
Mounjaro: the once-weekly tirzepatide pen
Mounjaro is the brand name for tirzepatide, a once-weekly injectable prescription medicine made by Eli Lilly. In the UK it is licensed for weight management in adults and for type 2 diabetes. It comes as a pre-filled multi-dose pen (KwikPen) in six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg.1
The dose ladder
Everyone starts Mounjaro on 2.5mg once a week. This starting dose is about letting your body adjust, not about weight loss itself. After at least 4 weeks the dose rises to 5mg, and can then step up by 2.5mg at a minimum of 4-week intervals (7.5mg, 10mg, 12.5mg) up to a maximum of 15mg weekly, depending on how you respond and tolerate it. Many people settle at a maintenance dose of 5mg, 10mg or 15mg. Higher is not automatically better, and your prescriber will guide the right pace.1
What the pen contains
Each KwikPen contains four weekly doses.
Type 2 diabetes context
Mounjaro is also licensed for type 2 diabetes, where it improves blood sugar control (HbA1c) and supports weight loss. If you have type 2 diabetes, treatment and monitoring are coordinated differently, so tell your prescriber and your usual diabetes team so care stays joined up.1 Our blog explains diabetes medication and weight loss in more depth.
How we supply it
We supply Mounjaro through official LillyDirect supply, direct from Eli Lilly's UK distribution, as genuine KwikPens. The consultation is free and reviewed by a GPhC-registered prescriber; payment is taken when you place the order, and if the prescriber decides the treatment is not suitable, the order is refunded automatically in full. Repeat orders re-check suitability, so nothing ships automatically. Standard prices are £169.99 at 2.5mg and £218.99 at 5mg, and every later order is £25 off the standard price.
06 · Wegovy and liraglutide
Wegovy and liraglutide: the other injectables
Wegovy and liraglutide are the other licensed weight loss injectables, and both belong to the GLP-1 family. Wegovy (semaglutide) is given once weekly, with pens of 0.25mg, 0.5mg, 1mg, 1.7mg and 2.4mg.
Wegovy versus Mounjaro
The honest answer to "which is better, Wegovy or Mounjaro?" is that it depends on the person. The mechanisms differ: semaglutide is a single-action GLP-1 medicine, while tirzepatide activates GIP and GLP-1 receptors together.1 SURMOUNT-5 was the first large head-to-head trial of tirzepatide and semaglutide. A prescriber can weigh tolerability, your medical history, other medicines, cost and your preferences. Wegovy prices from our site start at £99.99 for a first pen, so check the live price and availability at the time of order.
Liraglutide: the daily option
Liraglutide, sold as Saxenda and in products such as Erly, is supplied at a concentration of 6mg per millilitre. It is a daily injection, unlike once-weekly Mounjaro and Wegovy.
Switching between medicines
People sometimes move between medicines because of tolerability, cost or progress. Switching should always be decided with a prescriber, who can choose a safe starting dose and tell you when to stop the old product. If you want to see how the products are named and grouped, our guide to the names of weight loss medication sorts brands from active ingredients.
Choosing between them
Useful questions to bring to a consultation: how do I feel about daily versus weekly injections; do I have any conditions or medicines that affect the choice; what is my budget over a full year; and how will I review progress? Because costs vary by dose and provider, the cheapest injectable for weight loss page looks at price in detail. Price should not be the only factor, though, and a clinical review matters more than any promotional offer.
07 · Non-injectable options
Non-injectable weight loss medication
Non-injectable options do exist: licensed GLP-1 tablets such as Wegovy tablets (oral semaglutide) and Foundayo (orforglipron) are available as film-coated or oral tablets.2021
Why people ask about tablets
The most common reason is simply needle reluctance. Pen needles are very fine and many people find the weekly injection easier than expected, and every order includes needles, a sharps bin and injection guidance. If you still prefer tablets, tell the prescriber, who can discuss what is licensed and suitable for you.
The "poor man's Ozempic" question
"Poor man's Ozempic" and "nature's Ozempic" are marketing phrases for low-cost supplements, with berberine the best-known example. They are not licensed medicines, and they do not carry the same oversight or evidence base as prescription treatments. Dosing is not standardised and quality varies between sellers. Be wary of dramatic weight-loss claims attached to them. Anything sold as a shortcut that skips assessment deserves scepticism, and the MHRA publishes counterfeit medicine alerts for a reason.7
Over-the-counter and other products
Fibre products, over-the-counter capsules and similar items are available cheaply without assessment. If you are comparing them with injectables, ask what evidence supports them, whether they are licensed for weight management, and who monitors you. For peptides sold online, read our explainer on injectable peptides for weight loss, which sets out why unlicensed products carry unknown dosing accuracy and no safety data.
Other manufacturers' injectables
If a company's name appears in an advert for a weight loss injection, check the product against the licensed names, and check the seller on the GPhC register.12 A genuine UK pharmacy will be listed there.
08 · Realistic results
Realistic pace of weight loss
Weight loss on injectables is gradual by design, so it is not realistic to expect a large change within a few weeks. The first weeks on 2.5mg are an adjustment phase and losses are usually modest. Most measurable progress builds from 5mg onward, month by month. Trials measured results at 72 weeks, so think in months, not days, and judge progress by trend, not individual weigh-ins.1
Can you lose a lot of weight in a short time?
People often ask whether they can reach a specific target in a couple of months. Promising a specific number would be misleading. The licensed dose ladder is built around slow, tolerable increases, and altering it to speed things up is not supported. Early loss on any plan includes water weight, so the trend over weeks matters more than any single weigh-in.1
What the starting weeks feel like
Experiences differ widely: some people notice appetite change and early loss in week one, while others feel little until a higher dose. Both are normal. Mild nausea, altered appetite and tiredness in the first days after each injection are the commonest early effects and usually settle.1
How the prescriber reviews progress
Treatment response is reviewed by your prescriber. If you have lost less than 5% of your starting weight after 6 months on the highest dose you can tolerate, your prescriber will discuss whether continuing or stopping is right for you.1 That review is the point of clinical oversight: the aim is to continue only what is working for you. With us, ongoing monthly reviews, dose titration and follow-up assessments by the prescribing team are included, along with side-effect support.
Trial results in context
The SURMOUNT-1 trial reported results over 72 weeks, and individual results vary widely around any average.2 Trial averages do not predict your own result. What you can expect is a gradual trend that depends on dose, tolerance, food choices and activity.
What helps you stay on track
Practical habits make a difference: weigh yourself on a regular schedule rather than daily, keep notes on appetite and side effects, and bring them to reviews. The free GLPTrackr companion app (iOS and Android) lets you track your GLP-1 journey in one place, including injection days and symptoms. Treat the app as a diary, not as a judge of progress.
09 · Safety and what to avoid
Safety, interactions and what to avoid
The main things to avoid on Mounjaro are altering the dose, doubling up after a missed dose, freezing the pen, and keeping your prescriber in the dark about other medicines. Because Mounjaro slows stomach emptying, it can affect how quickly some oral medicines are absorbed, particularly when you start treatment or increase the dose. Tell your prescriber about everything you take, especially warfarin or other narrow-margin medicines, insulin, or sulfonylureas (where doses may need reducing to avoid low blood sugar). No adjustment is needed for paracetamol.1
Contraception
The medicine can reduce absorption of oral contraceptives because stomach emptying slows. The SmPC advises switching to a non-oral method, or adding a barrier method (such as condoms), for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase.1 Discuss your contraception with the prescriber before you start, and read the MHRA guidance.7
Missed doses
If you miss a dose, take it as soon as you can within 4 days (96 hours) of the scheduled time, then carry on with your usual day. If more than 4 days have passed, skip the missed dose entirely and take the next one on your normal day — never take two doses within 3 days of each other.1
Questions about lasting harm
People ask whether these medicines can cause permanent damage. Mounjaro is not known to damage kidneys or liver directly; the practical risk is indirect, because severe vomiting or diarrhoea can cause dehydration, which can strain the kidneys, so keep fluids up and get medical help straight away if you cannot keep fluids down. Your prescriber can talk through the risks that apply to you. Regulators have looked specifically at whether GLP-1 medicines are linked to low mood or suicidal thoughts: the EMA's safety committee reviewed the evidence and concluded in 2024 that it does not support a causal link, and the MHRA keeps this under continuous review.17
If you have thoughts of harming yourself or ending your life, get help straight away. Call 999 or go to A&E if you are in immediate danger. In England you can call NHS 111 and choose the mental health option, any time. You can also call Samaritans free on 116 123, day or night. Tell your prescriber about any change in your mood while taking Mounjaro. If you become pregnant during treatment, stop the medicine and tell your prescriber promptly. Mounjaro must not be used during pregnancy, and it should be stopped at least one month before trying to conceive.
Reporting problems
If you have a new symptom, speak to your prescriber, and report suspected side effects through the MHRA Yellow Card scheme.19 Reports help regulators spot issues early, and you do not need to be certain the medicine caused the problem to make one.
10 · NHS versus private
NHS access versus private treatment
Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions). Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.46
Asking your GP
Start by asking your GP whether you qualify under the current phase and how local services are organised. The NHS describes the medicine on its tirzepatide page.5 NHS access to Wegovy runs through specialist weight-management services; ask your GP. A prescription from the NHS carries the standard England charge of £9.90 per item unless you are exempt, though that does not apply in every UK nation, so check locally.
When private treatment makes sense
Private treatment suits people who do not yet fall into an NHS group, who prefer not to wait, or who want faster follow-up. It still needs a proper clinical assessment. The consultation with us is free and reviewed by a GPhC-registered prescriber, and our registration (GPhC 9012878) can be checked on the public register.12
Planning the cost
If you step up after 4 weeks on each dose, your first four pens (2.5mg to 10mg) cost £959.96 at standard prices. A first year costs £2,711.88 if you stay on 5mg after your 2.5mg starting pen, up to £3,599.88 if you step up through every dose to 15mg. These are standard prices before discounts: a new customer's first order is £40 less with code FIRST40, and an automatic £25 reorder discount applies to every future order (code DOSE25). Across the UK pharmacies we track, Mounjaro pens ranged from £143.96 to £339.00 per month as of 10 October 2026.
Paying and committing
You can pay by Visa or Mastercard, with Klarna, or through pay-monthly options. There are no subscriptions, and repeat orders always re-check suitability. Delivery is free next-day tracked in temperature-controlled packaging, with same-day dispatch when ordered by 3pm. Saturday delivery is £14.99. The price shown is the price paid, with no hidden fees.
11 · Injecting, storage, travel
Injecting, storing and travelling with your pen
Mounjaro is injected under the skin (subcutaneously) once a week, on the same day each week, at any time of day, with or without food. Licensed injection sites are the stomach area (at least 5cm from the belly button), the front of the thigh, or the back of the upper arm if someone else gives the injection. Rotate the site with each dose. Each KwikPen contains four weekly doses.1
Choosing a day and time
There is no "best" time of day: Mounjaro works the same morning or evening, with or without food. What matters is the same day each week. Pick a day and time you will remember. Many people choose a weekend morning so early side effects fall on days off, and then stick to it.1
You can change your weekly injection day if needed, as long as at least 3 days (72 hours) have passed since your last dose.1
Storage
Keep Mounjaro pens in a fridge at 2–8°C and never freeze them. Once in use, a pen can be kept out of the fridge not above 30°C for up to 30 days — useful for short trips — after which it should be discarded. Keep the pen cap on to protect it from light, and never use a pen that has been frozen.1
Travelling
You can fly with Mounjaro. Carry pens in hand luggage (hold luggage can fall below freezing), ideally in a cool bag with the prescription label or a copy of your prescription. In-use pens tolerate up to 30 days not above 30°C, so most holidays need no special arrangements; for hot climates use an insulated pouch. Check destination rules for travelling with prescription injectables before you fly.1
Unopened pens should be kept in the fridge and keep until the expiry date printed on the box. If an unopened pen has been out of the fridge, check with the pharmacy before using it rather than relying on a remembered day limit, because figures circulating online often come from other countries' labels.13
Support when you need it
Every order includes needles, a sharps bin and injection guidance. If you have questions about technique or side effects, our support team is available Monday to Friday, 9am to 5pm, by email at support@everydaymeds.co.uk, through the account portal chat, or by phone on 0333 207 0413. Existing customers can use the weight loss injectable login to manage their account and reviews.
12 · Serious side effects
Serious side effects: when to get help straight away
Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.1 Severe, persistent stomach pain, with or without being sick, could be pancreatitis: stop using Mounjaro and get medical help straight away.
How ordering works
How ordering works at EverydayMeds
Three steps, with our pharmacy team alongside you.
Step 1: Online consultation — 5–10 minutes
Complete a confidential health questionnaire covering BMI, medical history and current medication. No payment is taken until you're approved.
Step 2: Prescriber review — usually same day
A UK registered prescriber checks your suitability against the licensed criteria (BMI ≥30, or ≥27 with a weight-related condition) and contraindications, and confirms your starting dose.
Step 3: Next-day tracked delivery
Dispensed by our GPhC-registered pharmacy in temperature-controlled packaging with needles and a sharps bin included. Orders approved by 3pm for next-day tracked delivery.
Prescription and dispatch follow clinical approval. Confirm current delivery options when ordering.
Afterwards you're not on your own: dose-change reviews are built in before each step up, our pharmacist team is available for side-effect questions, and repeat orders re-check suitability rather than auto-shipping.
Your questions, answered
Mounjaro price UK — frequently asked questions
Answers to common questions about Mounjaro prices, NHS access and ongoing treatment.
Ask our pharmacy teamWhat are weight loss injections?
Which is better, Wegovy or Mounjaro?
What is known as the "poor man's Ozempic"?
What should I avoid while taking Mounjaro?
Can I lose a lot of weight in just a couple of months?
Will I regain weight if I stop?
Can Wegovy do permanent damage?
What's the hardest age to lose weight?
Are there non-injectable weight loss medications?

Clinically reviewed by
Mahommed Zunaid Ayub Patel
Superintendent Pharmacist
Accountable for the safe running of our registered pharmacy — from dispensing checks to delivery.
GPhC registration no. 2217101 · check the GPhC register
- Reviewed
- Last updated
- Next review
How we source our information
How we source our information: every clinical statement on this page is drawn from the sources below. Our prices are shown live from our pharmacy's product listings, and competitor prices show the date they were collected.
Sources — 12 references
- Mounjaro KwikPen — Summary of Product Characteristics (SmPC), electronic medicines compendium (EMC), 2026
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med 2022;387:205–216
- NICE TA1026 — Tirzepatide for managing overweight and obesity, including the practical prescribing guide
- NHS — Tirzepatide: medicine to manage type 2 diabetes and treat obesity
- NHS England — Weight management injections: rollout guidance
- MHRA — guidance on contraception with GLP-1/GIP medicines; counterfeit medicine alerts and Yellow Card scheme
- GPhC — public register of pharmacies and pharmacy professionals
- Mounjaro KwikPen — Patient Information Leaflet (emc)
- Wegovy — Summary of Product Characteristics (SmPC), electronic medicines compendium (EMC)
- MHRA Yellow Card scheme — report a side effect
- Wegovy tablets (oral semaglutide) — Summary of Product Characteristics (SmPC), electronic medicines compendium (EMC), 2026
- Foundayo (orforglipron) film-coated tablets — Summary of Product Characteristics (SmPC), electronic medicines compendium (EMC), 2026
EverydayMeds is operated by OVIO Ltd · GPhC-registered pharmacy 9012878 · Registered premises, Leicester · Superintendent Pharmacist: Mahommed Zunaid Ayub Patel


